Celofen 60 mg (Loxoprofen Sodium Hydrate)

Adult dose

1. For indications 1 and 2 Typically, adults are administered Loxoprofen Sodium (as anhydrous form) 60 mg (1 tablet) orally three times a day. For single-dose therapy, 60 to 120 mg (1 to 2 tablets) may be given. Adjust as necessary based on symptoms. It is advisable to avoid taking on an empty stomach. 2. For indication 3 Typically, adults are administered Loxoprofen Sodium (as anhydrous form) 60 mg (1 tablet) orally.

This medication can cause gastrointestinal bleeding if taken by individuals who regularly consume three or more alcoholic beverages a day, so it is essential to consult a doctor or pharmacist. This medication may affect the cardiovascular system, leading to serious cardiovascular issues such as myocardial infarction or stroke. Individuals with cardiovascular disease or risk factors must exercise caution. This medication may cause serious adverse reactions such as gastrointestinal bleeding, ulcers, and perforation, with older adults having a higher risk. Therefore, gastrointestinal bleeding symptoms should be closely monitored during use. Individuals with a history of gastric ulcers, severe blood, liver, kidney, or heart diseases, those allergic to this medication or similar medications, pregnant women in the late stages, or those who are nursing should not take this medication. Individuals with a history of peptic ulcers, liver, kidney, or heart issues, asthma, hypertension, elderly individuals, and pregnant women in early or mid-pregnancy should use this medication cautiously and follow a doctor's guidance. This medication may cause allergic reactions such as rashes, itching, and urticaria, with severe cases potentially resulting in shock or anaphylaxis; if abnormal symptoms occur, discontinue use immediately and consult a healthcare professional. Gastrointestinal symptoms may include abdominal pain, nausea, vomiting, diarrhea, and bleeding; severe cases require immediate treatment. This medication may induce neurological symptoms such as drowsiness, dizziness, and headaches, necessitating caution while driving or operating machinery. Due to potential effects on liver and kidney function, regular monitoring and testing are needed, and if abnormal signs are detected, use should be discontinued immediately. The risk of side effects may increase when used with other non-steroidal anti-inflammatory drugs, so co-administration should be avoided, and any concurrently used medications should be disclosed as there may be interactions. This medication should be avoided during pregnancy, especially in the late stages, as it may pose risks to the fetus, and it is advisable not to use while breastfeeding. Safety in children has not been established, and caution is warranted for elderly individuals. This medication should be stored out of the reach of children, and it should not be transferred to other containers.

Serious side effects

Urticaria, severe swelling (angioedema), tightness in the chest, difficulty breathing, gastric ulcers, hematemesis, melena, shock, hypotension, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, acute generalized exanthematous pustulosis, liver dysfunction (including jaundice), acute renal failure, dyspnea, asthma attacks, aseptic meningitis (fever, headache, nausea, vomiting, neck stiffness, altered consciousness), severe allergic reactions, severe skin reactions

Mild side effects

• Itching
• rash
• abdominal pain
• discomfort in the stomach
• loss of appetite
• nausea
• vomiting
• diarrhea
• constipation
• feeling of chest heat

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture and kept at a temperature between 1°C and 30°C. Proper storage will maintain the drug's effectiveness and ensure safe use.

Appearance

Pale pink round tablets

Package unit

30 tablets/bottle, 500 tablets/bottle